Palo Alto, Calif., Latham & Watkins partner Tracy Edmonson sees Angiotech Pharmaceuticals Inc.’s recent acquisition of American Medical Instruments Holdings Inc. as an example of the irrelevance of national borders.

Based in Vancouver, British Columbia, Angiotech develops treatments for diseases and complications associated with medical device implants, surgical interventions and acute injury or trauma. The company closed its $785 million cash acquisition of the Chicago specialty medical device manufacturer in March.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]